These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Myasthenia gravis and Lambert-Eaton myasthenic syndrome. Sanders DB; Guptill JT Continuum (Minneap Minn); 2014 Oct; 20(5 Peripheral Nervous System Disorders):1413-25. PubMed ID: 25299290 [TBL] [Abstract][Full Text] [Related]
45. Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: Review of recent literature. Chiou-Tan FY; Gilchrist JM Muscle Nerve; 2015 Sep; 52(3):455-62. PubMed ID: 26109387 [TBL] [Abstract][Full Text] [Related]
46. Acquired disorders of the neuromuscular junction. O'Neill GN Int Anesthesiol Clin; 2006; 44(2):107-21. PubMed ID: 16849959 [No Abstract] [Full Text] [Related]
47. Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients. Newsom-Davis J; Leys K; Vincent A; Ferguson I; Modi G; Mills K J Neurol Neurosurg Psychiatry; 1991 May; 54(5):452-3. PubMed ID: 1650816 [TBL] [Abstract][Full Text] [Related]
48. Botulinum toxin type A therapy for cervical dystonia. Castelão M; Marques RE; Duarte GS; Rodrigues FB; Ferreira J; Sampaio C; Moore AP; Costa J Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003633. PubMed ID: 29230798 [TBL] [Abstract][Full Text] [Related]
49. [Spinal muscular atrophy with features of myasthenia gravis and Eaton-Lambert syndrome. A case report]. Ono S; Kurisaki H Rinsho Shinkeigaku; 1988 May; 28(5):497-500. PubMed ID: 2850884 [No Abstract] [Full Text] [Related]
50. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis. Baslo MB; Deymeer F; Serdaroglu P; Parman Y; Ozdemir C; Cuttini M Neuromuscul Disord; 2006 Jul; 16(7):454-8. PubMed ID: 16806929 [TBL] [Abstract][Full Text] [Related]
51. Myasthenia gravis: lessons for the emergency physician. Smulowitz PB; Zeller J; Sanchez LD; Edlow JA Eur J Emerg Med; 2005 Dec; 12(6):324-6. PubMed ID: 16276268 [TBL] [Abstract][Full Text] [Related]
52. [Myasthenia, from the internist's point of view]. Eymard B Rev Med Interne; 2014 Jul; 35(7):421-9. PubMed ID: 24112993 [TBL] [Abstract][Full Text] [Related]
53. Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome. Miralles F Med Biol Eng Comput; 2016 Nov; 54(11):1761-1778. PubMed ID: 27016366 [TBL] [Abstract][Full Text] [Related]
54. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome. Maddison P; McConville J; Farrugia ME; Davies N; Rose M; Norwood F; Jungbluth H; Robb S; Hilton-Jones D J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):671-3. PubMed ID: 20392977 [TBL] [Abstract][Full Text] [Related]